Penn Radiology Oncologic Imaging: Optimizing Patient Care Agenda
Session 1: Current State-of-the-Art and Emerging Techniques
| MRI State-of-the-Art and Emerging Applications | Mark A. Rosen, MD, PhD |
| CT State-of-the-Art and Emerging Applications | Susan Hilton, MD |
| US State-of-the Art and Emerging Applications | Steven C. Horii, MD, FACR, FSIIM |
| SPECT/CT and PET/CT State-of-the Art and Emerging Applications | Daniel A. Pryma, MD |
| Tomosynthesis: Technique, Current and Emerging Applications | Emily F. Conant, MD |
Session 2: Head and Neck Cancers
| Evaluation of Sinonasal and Skullbase Neoplasia | Laurie A. Loevner, MD |
| The Role of Ultrasound in Detecting Thyroid Cancer | Hanna M. Zafar, MD |
| Imaging of Laryngeal Cancer | Laurie A. Loevner, MD |
Session 3: CT Screening for Lung Cancer 1
| CT Screening for Lung Cancer: Rationale and Evidence Base | Drew A. Torigian, MD, MA |
| Establishing a Successful Lung Cancer Screening Program | Ana S. Kolansky, MD |
| Screening CT: Optimizing Scan Techniques and Reporting | Eduardo M. Barbosa, MD |
| ACR LungRADS: Structured Nodule Reporting and Management System | Ana S. Kolansky, MD |
Session 4: CT Screening for Lung Cancer 2
| Risk/Benefit & Over-diagnosis in Lung Cancer Screening | Eduardo M. Barbosa, MD |
| Patient Conversations: Shared Decision Making and Counseling | Anil Vachani, MD |
| Future Directions in the Screening of Lung Cancer | Anil Vachani, MD |
| Case Presentations and Panel Discussion | Multiple Faculty Members |
Session 5: Clinical Updates and Imaging Correlates
| Medical Oncology: Update on Immune-modulating Therapeutics and Imaging Correlates | Tara C. Gangadhar, MD |
| AJCC Staging, Standard of Care Therapy, Breast and Gynecologic Malignancies | Lilie Lin, MD |
| Imaging of Gynecologic Cancers: Focus on Treatment Planning | Lilie Lin, MD |
Session 6: Thoracic Malignancies
| Ultrasound in Breast Imaging | Susan Roth, MD |
| Indications for MR Imaging of the Breast | Susan Roth, MD |
| Lung Cancer Staging, Standard of Care and Imaging Strategies | Drew A. Torigian, MD, MA |
Session 7: GI Malignancies
| Esophageal & Gastric Cancer: AJCC Update and Standard of Care | Daniel A. Pryma, MD |
| Fluorscopy After Oncologic GI Surgery | Stephen E. Rubesin, MD |
| CT Colonography, Techniques, Interpretations and Reimbursement | Hanna M. Zafar, MD |
Session 8: Other Abdominal Malignancies
| Liver Imaging for Primary and Metastic Disease (MR) | Anil Chauhan, MD |
| Liver Directed Therapy: Treatment Options, Technical Aspects and Work-up | Deepak Sudheendra, MD, RPVI |
| Prostate Cancer: Initial Imaging Work-up and Imaging in the Face of Rising PSA | Anil Chauhan, MD |
| Prostate Cancer Treatment Options and Toxicities | Daniel A. Pryma, MD |
| Renal Masses and Cancers: Imaging Work-up, Biopsies and Surgical Approaches | Nicholas Papanicolaou, MD |
Session 9: Neuroendocrine Tumors
| Neuroendocrine Tumors: Work-up, Symptoms and Palliative Options | David C. Metz, MD |
| Neuroendocrine Tumors: Chemotherapeutic Options and Imaging Implications | Arturo Loaiza-Bonilla, MD |
| Radiopharmaceutical Imaging and Therapy of Neuroendocrine Tumors | Daniel A. Pryma, MD |
Session 10: GI Malignancies
| Lymphoma Imaging, Treatments and Follow-up | Jakub Svoboda, MD |
| Image-guided Adaptive Therapy in Lymphoma | David A. Mankoff, MD, PhD |
| Melanoma: Review of Staging and Treatment Options | Daniel A. Pryma, MD |
| Melanoma: Patterns of Recurrence and Toxicity in the Era of Immune-modulating Therapy | David A. Mankoff, MD, PhD |
| Musculoskeletal Malignancies: Imaging Patterns, Treatments and Pitfalls | Madhura A. Desai, MD, PhD |




Reviews
There are no reviews yet.